Organoid_Derivation_Project__TGS - EGA European Genome-Phenome Archive

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD00001004368	Targeted gene sequencing of cancer driver genes to determine the driver mutations present in newly-derived cancer organoid models	Illumina HiSeq 4000	10
EGAD00001004999	Sequencing of tissue samples and their derived organoids from oesophageal, pancreatic and colorectal cancer patients.	Illumina HiSeq 4000	41
EGAD00001005958	Sequencing of tissue samples and their derived organoids from oesophageal, pancreatic and colorectal cancer patients.	Illumina HiSeq 4000	11
EGAD00001011089	Sequencing of tissue samples and their derived organoids from oesophageal, pancreatic and colorectal cancer patients. . This dataset contains all the data available for this study on 2023-06-22.	Illumina HiSeq 4000	41
EGAD00001015425	Sequencing of tissue samples and their derived organoids. This dataset contains a subset of colorectal and colorectal liver metastasis samples.	Illumina HiSeq 4000	1
EGAD00001015468	Targeted gene sequencing data from cancer patient-derived organoids and their matched tumour tissue samples. Part of a study to include genomic and transcriptomic sequencing data, along with CRISPR screening data from cancer patient-derived organoids and matched tumour tissues. Some organoids were developed as part of the Human Cancer Models Initiative (HCMI) in collaboration with Cancer Research UK (CRUK). The study includes organoids derived from colorectal, oesophageal, ovarian, pancreatic, and stomach cancer samples.	HiSeq X Ten Illumina HiSeq 4000 Illumina NovaSeq 6000	1
EGAD00001015470	RNA sequencing data from cancer patient-derived organoids. Part of a study to include genomic and transcriptomic sequencing data, along with CRISPR screening data from cancer patient-derived organoids and matched tumour tissues. Some organoids were developed as part of the Human Cancer Models Initiative (HCMI) in collaboration with Cancer Research UK (CRUK). The study includes organoids derived from colorectal, oesophageal, ovarian, pancreatic, and stomach cancer samples.	Illumina HiSeq 4000 Illumina NovaSeq 6000	1